OTCMKTS:CWBR
CohBar Inc Stock News
$0.88
+0 (+0%)
At Close: May 17, 2024
CohBar to Present at the 2020 BIO CEO & Investor Conference
02:00pm, Tuesday, 28'th Jan 2020
CohBar, Inc. (CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics (MBTs) to treat chronic diseases and extend healthy lifespan, announced today that its Chief Exec
CohBar Appoints Jordyn Tarazi as Director of Investor Relations
02:00pm, Wednesday, 22'nd Jan 2020
CohBar, Inc. (CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics (MBTs) to treat chronic diseases and extend healthy lifespan, announces the appointment of Jordyn
CohBar Discovers Novel Peptide Inhibitors of CXCR4, a Key Regulator of Tumor Growth and Metastasis
02:00pm, Wednesday, 08'th Jan 2020
CohBar, Inc. (CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics (MBTs) to treat chronic diseases and extend healthy lifespan, today announced the discovery of a
Hedge Funds Have Never Been This Bullish On CohBar, Inc. (CWBR)
01:04am, Tuesday, 24'th Dec 2019
We at Insider Monkey have gone over 752 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of Se
CohBar Confirms Anti-fibrotic Effect of a Novel Peptide in a Therapeutic Model of Idiopathic Pulmonary Fibrosis
02:00pm, Monday, 16'th Dec 2019
CohBar, Inc. (CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases and extend healthy lifespan, today announced new preclinical
CohBar Reports Third Quarter 2019 Financial Results and Business Update
09:04pm, Wednesday, 06'th Nov 2019
MENLO PARK, Calif., Nov. 06, 2019 -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related.
April Dividend Income from YOU the Bloggers! - Dividend Diplomats
12:00pm, Tuesday, 21'st May 2019
52 bloggers earned over $38,500 in dividend income this April! Here is the next installment in our monthly series. See how each blogger did this month.
A Hands-On Introduction to Deep Q-Learning using OpenAI Gym in Python
04:27am, Thursday, 18'th Apr 2019
Learn what is deep Q-learning, how it relates to deep reinforcement learning, and then build your very first deep Q-learning model using Python!
Fleet Complete finalizes partnership with Ontario Teachers’ Pension Plan
06:05pm, Friday, 01'st Mar 2019
Fleet Complete, a tech company operating in the connected vehicle space, has closed an investment partnership with the Ontario Teachers' Pension Plan.
October Dividend Income From YOU the Bloggers! - Dividend Diplomats
01:00pm, Tuesday, 20'th Nov 2018
Happy early Thanksgiving everyone! 2018 has been such an amazing year for some many reasons. There is just a lot to be thankful for and hopefully all of use take some time this week to reflect and
Reinforcement Learning: Introduction to Monte Carlo Learning using the OpenAI Gym Toolkit
04:42am, Monday, 19'th Nov 2018
This detailed article covers an introduction to the Monte Carlo Method of learning using the popular OpenAI Gym library - with Python implementation!
Towergate and Broker Network owners HPS and MDP buy Compass - Insurance Age
12:35pm, Thursday, 01'st Mar 2018
Compass sells after its 2016 MBO from Arthur J Gallagher.
My Cigarette Problem
10:00pm, Monday, 16'th Mar 2015
See Lanny's investing cigarette problem as he owns large tobacco corporations - one that is bigger and one that is getting acquired. What should he do?
